Literature DB >> 15809715

Involvement of the ras genes in female genital tract cancer.

Ioannis N Mammas1, Alexandros Zafiropoulos, Demetrios A Spandidos.   

Abstract

Human carcinogenesis is a multistep process involving complicated genetic events in which several onco-genes and oncosuppressor genes are implicated. The role of ras oncogenes in cellular transformation and apoptosis has been extensively examined and the dual role of ras as oncogene and oncosuppressor gene has been supported. Activation of ras occurs either by genomic alterations such as point mutations or by modulation of Ras protein expression. Many molecular and immunohistochemical studies have focused on ras activation in a wide range of human tumours. In this review, we summarize available information regarding the genomic and expression alterations of ras oncogenes in cervical, endometrial and ovarian cancer. Gynecological malignancies represent some of the most well- studied types of human cancer concerning ras activation and its possible use in clinical practice.

Entities:  

Mesh:

Year:  2005        PMID: 15809715

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

Review 1.  Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Authors:  Maria Koutsaki; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2011-12-09       Impact factor: 3.201

2.  Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.

Authors:  Kristi L Berger; Felicia Barriga; Michael J Lace; Lubomir P Turek; Gideon J Zamba; Frederick E Domann; John H Lee; Aloysius J Klingelhutz
Journal:  Virology       Date:  2006-08-30       Impact factor: 3.616

3.  K-ras mutations in lung tumors and tumors from other organs are consistent with a common mechanism of ethylene oxide tumorigenesis in the B6C3F1 mouse.

Authors:  Hue-Hua L Hong; Christopher D Houle; Thai-Vu T Ton; Robert C Sills
Journal:  Toxicol Pathol       Date:  2007-01       Impact factor: 1.902

4.  Biomarkers in endometrial cancer: Possible clinical applications (Review).

Authors:  Kouji Banno; Iori Kisu; Megumi Yanokura; Kosuke Tsuji; Kenta Masuda; Arisa Ueki; Yusuke Kobayashi; Wataru Yamagami; Hiroyuki Nomura; Eiichiro Tominaga; Nobuyuki Susumu; Daisuke Aoki
Journal:  Oncol Lett       Date:  2012-03-26       Impact factor: 2.967

Review 5.  Ovarian cancer biomarker discovery based on genomic approaches.

Authors:  Jung-Yun Lee; Hee Seung Kim; Dong Hoon Suh; Mi-Kyung Kim; Hyun Hoon Chung; Yong-Sang Song
Journal:  J Cancer Prev       Date:  2013-12

6.  Genetic variations in the SULF1 gene alter the risk of cervical cancer and precancerous lesions.

Authors:  Efthimios Dardiotis; Vasileios Siokas; Antonios Garas; Evangelos Paraskevaidis; Maria Kyrgiou; Georgia Xiromerisiou; Efthimios Deligeoroglou; Georgios Galazios; Emmanuel N Kontomanolis; Demetrios A Spandidos; Aristidis Tsatsakis; Alexandros Daponte
Journal:  Oncol Lett       Date:  2018-07-06       Impact factor: 2.967

7.  Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases.

Authors:  Daniel E Machado; Plínio T Berardo; Celia Y Palmero; Luiz E Nasciutti
Journal:  J Exp Clin Cancer Res       Date:  2010-01-19

8.  Mutational analysis of KRAS, BRAF, and TP53 genes of ovarian serous carcinomas in Korean women.

Authors:  Yun-Hyun Cho; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Kyu-Rae Kim; Joo-Hyun Nam; Young-Tak Kim
Journal:  Yonsei Med J       Date:  2009-04-30       Impact factor: 2.759

9.  Differential tissue-specific protein markers of vaginal carcinoma.

Authors:  K Hellman; A A Alaiya; S Becker; M Lomnytska; K Schedvins; W Steinberg; A-C Hellström; S Andersson; U Hellman; G Auer
Journal:  Br J Cancer       Date:  2009-03-24       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.